2001年～2003年广东省部分医院糖尿病治疗用药分析  

Analysis of the Drugs Used for Diabetes in Some Hospitals of Guangdong Province During the Period 2001～2003

作　　者：杨威[1] 伍杰雄[2] 

机构地区：[1]中山大学附属第一医院,广州市510080 [2]中山大学医院管理处,广州市510080

出　　处：《中国医院用药评价与分析》2005年第1期25-27,共3页Evaluation and Analysis of Drug-use in Hospitals of China

摘　　要：目的 :研究广东省部分医院 2 0 0 1年～ 2 0 0 3年糖尿病治疗用药金额 ,以了解广东省糖尿病治疗药物的应用情况及其变化趋势。方法 :本文采集“广东省药学会医院用药信息网”收集的购药统计数据 ,对广东省部分医院 2 0 0 1年～ 2 0 0 3年糖尿病治疗药物用药金额进行统计、排序 ,并加以分析。结果与结论 :2 0 0 1年～ 2 0 0 3年糖尿病治疗药物销售金额虽然在药物总金额中所占的比例基本保持稳定 ,但其绝对金额却正在逐年上升 ;胰岛素制剂占有市场较大份额 ,市场竞争亦较激烈 ;在口服降糖药中 ,胰岛素增敏剂的市场前景看好。OBJECTIVE:To investigate the amount of money spent on the drugs used for diabetes in some hospitals of Guangdong province during the period 2001～2003, in order to know the use and the changing tendency of the drugs used for diabetes in Guangdong. METHODS: By using drug-purchase statistical dada collected from “Hospital medication information net of pharmaceutical society of Guangdong province ”, the amount of money on the drugs used for diabetes in some hospitals in Guangdong during the period 2001～2003 were added up, ranked and analyzed. RESULTS & CONCLUSION: Although the proportion of selling amount of money spent on the drugs used for diabetes to total amount of money of the whole drugs was basically stable during 2001～2003, their absolute amount of money rose year by year; Insulin preparations occupied large part of the portion on the market and competition in market was also sharp.Of oral antidiabetic drugs, euglycemic agents have wide future on the market.

关 键 词：糖尿病 医院用药 治疗药物 治疗用药 药学会 胰岛素制剂 口服降糖药 金额 广东 份额 

分 类 号：R587[医药卫生—内分泌] R197[医药卫生—内科学]